Chronic graft-versus-host disease (cGVHD) is an autoimmune-like phenomenon resulting in morbidity and mortality following allogeneic bone marrow transplantation (BMT). Major salivary gland dysfunction and hyposalivation is one of the prevalent manifestations of cGVHD. We have used the B10.D2 to Balb/C cGVHD mice model in order to assess major salivary gland function in cGVHD, evaluating sialometric, sialochemical and histopathological parameters for almost 3 months. As cGVHD is a chronic debilitating disease it is of vast importance to evaluate these parameters on a prolonged longitudinal basis. We observed significant reduction in parotid salivary flow rate and disturbance in the salivary dynamic function in cGVHD mice in comparison to the normal and syngeneic transplanted controls. On days 18, 25, 46, 56 and 88 the mean flow rates of the cGVHD group were 37.4 ؎ 4.4 l/30 min, 40.5 ؎ 4.6 l/30 min, 32.5 ؎ 2.3 l/30 min, 22.2 ؎ 3.2 l/30 min and 14.8 ؎ 3.8 l/30 min, respectively, values which were lower than those of the syngeneic transplanted controls group by 42% (P Ͻ 0.04), 32% (P Ͻ 0.03), 44% (P Ͻ 0.01), 49% (P Ͻ 0.01) and 64% (P Ͻ 0.01), respectively. These changes in flow rates were paralleled by changes in the biochemical composition of the saliva. Moreover, the reduction in flow rates correlated with the degree of salivary gland destruction observed in the pathological slides. An inverse correlation was observed between the mean parotid salivary flow rate and the degree of fibrosis observed in the histopathological evaluation of the cGVHD mice (P Ͻ 0.01). Maximal flow rate 34.8 ؎ 4.6 l/30 min was observed when no fibrosis was observed while in mice with maximal fibrosis flow rates were minimal. This may point to the pathological mechanism leading to the major salivary gland dysfunction and hyposalivation observed in cGVHD. Thus, it may broaden our knowledge and provide the scientific background for designing better therapeutic strategies for this complication.
Chronic graft-versus-host disease (cGVHD) is an autoimmune-like complication following bone marrow and peripheral blood stem cell transplantation. [1] [2] [3] Chronic GVHD is known to cause damage to both the oral cavity and to the salivary glands. Salivary gland involvement in GVHD is indicated by increased dryness of the oral cavity, change in saliva compostition and histopathological changes in the labial minor salivary glands. 4 Salivary changes leading to 45-60% of hyposalivation have been reported to accompany cGVHD in both animal models and humans. [4] [5] [6] [7] [8] [9] [10] This xerostomia causes a significant morbidity to the patients as it debilitates both nutritional and communication functions and compromises their oral protective integrity. 11, 12 In spite of the obvious advantages of analyzing the salivary effects induced by the disease in an animal model, no such prolonged study is available evaluating these changes at the extended term. Furthermore, the only cGVHD animal model study available examined mainly functional parameters and only at one short-term time point -3 weeks after the induction of cGVHD. 7 The purpose of the current study was to evaluate various parotid sialometric, sialochemical and histopathological parameters at various time points during a 3 month period following the induction of cGVHD in a mouse model and to try to correlate between these parameters. These salivary changes were concomitantly compared with the general severity of the disease.
Materials and methods

Animal model and study design
The protocol for the cGVHD induction we used is based on the protocol published by Jaffee and Claman in 1983. 13 The donor mice (7-8 weeks old) were B10.D2 females (H-2 d , mis-b) who weighed 18-21 g and the recipient mice (12-13 weeks old) were BALB/c females (also H-2 d , misb) who weighed 20-22 g. To induce cGVHD in the experimental group (GVHD group), 25 ϫ 10 6 spleen cells from B10.D2 mice were injected intravenously into BALB/c mice which had received a day previously sublethal 850 cGy total body irradiation, using a linear accelerator 6 MeV with an irradiation rate of 230 cGy per minute. The day of irradiation was considered as day Ϫ1 and the day of the splenocyte injection as day 0. Two additional groups of mice served as controls: a syngeneic transplanted group (SYN group) in which the donor mice were also BALB/c and thus the recipient BALB/c mice were injected with 25 ϫ 10 6 syngeneic spleen cells and another group which was composed of normal BALB/c mice who were neither irradiated nor splenocyte injected (NORM group). All three groups of animals contained 30 animals each, were housed in laminar flow hoods for the 3 month long period of the experiment and were handled by the principles outlined in the Helsinki declaration. The animals were weighed on days 1, 7, 14, 18, 25, 36, 46, 56 and 88 of the experiment as total body weight was found by Jaffee and Claman 13 to be the most sensitive index for the severity of cGVHD. The salivary evaluation which included sialometric, sialochemical and histopathological analysis was conducted at five extended-term ('chronic') time points on days 18, 25, 46, 56 and 88.
Sialometric analysis
Flow rate examintion was done as previously described 7, 8 and briefly, animals were weighed, anesthetized with Pentobarbital (50 mg/kg intraperitoneally), and tracheotomies were performed. The main excretory duct of the parotid gland was identified through an extra-oral incision and cannulated with polyethylene tubing (PE10, Clay Adams, Parsipanny, NJ, USA). The procedure was performed by means of a dissecting microscope (OPMI-1, Zeiss, Oberkochen, Germany). Saliva was collected in pre-weighed tubes which were kept on ice during the procedure, following intraperitoneal injection with pilocarpine hydrochloride 5 mg/kg (Sigma Chemical, St Louis, MO, USA). Flow rate was measured by obtaining the volume of secreted saliva during 30 min at 5 min intervals following secretion of the first drop and the values were normalized and presented based on 100 g of body weight.
Histopathological evaluation
The parotid glands were fixed in a 4% formalin solution and paraffin embedded. Serial 4-m sections were prepared and stained by hematoxylin-eosin and the levels of picnosis, fibrosis and inflammatory infiltration were double blindly evaluated. Pathological scoring from 0 to 4 regarding these three criteria was given by an experienced pathologist (0 when there was no pathological finding and 4 when there were most severe, extended and widespread pathological alterations).
Sialochemical analysis
The collected saliva samples were centrifuged and the salivary constituents analyzed. Sodium and potassium were measured by flame photometry (Instrumentation Laboratories) and total protein by spectrophotometric methods (Perkin-Elmer, Norwalk, CT, USA) as previously described. 14, 15 
Statistical analysis
The statistical significance of the various data was computed following calculation of the mean results and standard errors. Student's t-test was used in evaluating the mean values of total body weights and of salivary flow rates and concentrations of sodium, potassium and protein, comparing the various experimental groups. The ANOVA test was used in order to compare values within the groups along the various time points of examination and the Pearson correlation coefficient was used in the correlation evaluations. (*) Denotes statistical significance of P Ͻ 0.05.
Results
Total body weight
From day 0 onwards there was a moderate increase in body weight of the normal mice (NORM group) up to 24 g on day 88 with a concomitant decrease in body weight of the GVHD group. This statistically significant decrease in body weight was moderate after day 18, profound after day 25 and from day 36 onwards there was stabilization in the body weight. From day 18 to day 88 the mean body weight of the GVHD mice decreased from 20.5 g to 17.5 g as compared to day 0 (P Ͻ 0.01). The syngeneic control mice demonstrated a constant mean body weight of 21 g during the experiment except for a slight temporary decrease in the first week and another decrease on day 88. In any case the mean body weight of these group (SYN group) was significantly higher than that of GVHD mice throughout the experiment except for day 1 ( Figure 1 ).
Sialometric analysis
Throughout the experiment the mean flow rates (parotid salivary volume secreted in 30 min) of the GVHD group were significantly lower than those of the SYN group and in turn the mean flow rates of the SYN group were lower than those of the NORM group. On days 18, 25, 46, 56 and 88 the mean flow rates of the GVHD group were 37.4 Ϯ 4.4 l/30 min, 40.5 Ϯ 4.6 l/30 min, 32.5 Ϯ 2.3 l/30 min, 22.2 Ϯ 3.2 l/30 min and 14.8 Ϯ 3.8 l/30 min, respectively, values which were lower than those of the SYN group by 42% (P Ͻ 0.04), 32% (P Ͻ 0.03), 44% (P Ͻ 0.01), 49% (P Ͻ 0.01) and 64% (P Ͻ 0.01), respectively ( Figure 2 ). As can be seen in Figure 2 during the experiment there was a continuous reduction in the mean flow rate values within the GVHD group itself and thus on days 56 and 88 these mean flow rates were lower than those found on day 18 by 40% (P Ͻ 0.03) and 60% (P Ͻ 0.01), respectively. The mean flow rates of the SYN group were lower, as mentioned above than those of the NORM group throughout the experiment and these differences reached statistically significant levels only on days 56 and 88 when these reductions were 44% (P Ͻ 0.01) and 55% (P Ͻ 0.01), respectively ( Figure 2 ). Another sialometric parameter analyzed was the dynamic pattern of salivary of flow rate during the measured 30 min as differentially examined every 5 min. This functional analysis also demonstrated a profound difference among the groups with the GVHD group mostly severely affected. On day 18 the mean flow rates after 10 and 30 min since stimulation in the GVHD group were 7.3 Ϯ 0.6 l/min and 4.4 Ϯ 0.8 l/min, respectively, values which were lower than those of the NORM group by 64% (P Ͻ 0.01) and 52% (P Ͻ 0.03), respectively ( Figure 3 ). On day 88 the reduction in mean flow rates of the GVHD group as compared with the NORM group, were 77% (P Ͻ 0.01) and 87% (P Ͻ 0.01), respectively ( Figure 3b ). These differential mean flow rate values of the GVHD group were lower than those of the SYN group as well, yet these reductions were not as profound. On day 18, at 10 min after stimulation, the mean flow rate of GVHD group was lower than that of the SYN group by 46% (P Ͻ 0.01). However, at 30 min the difference in mean flow rates between these two groups was not statistically significant ( Figure 3a) . On day 88 the reduction in mean flow rates of the GVHD groups as compared with the SYN group, at 10 and 30 min since stimulation were of 53% (P Ͻ 0.01) and 73% (P Ͻ 0.01), respectively ( Figure 3b ).
Sialochemical analysis
The salivary protein concentrations of the GVHD and two control groups at the different time points examined were not statistically different among themselves or within each group (Table 1) . In contrast to protein, the mean sodium concentration of the GVHD group continuously decreased from day 18 to day 46 (from 1.3 Ϯ 0.4 meq/ml to 0.8 Ϯ 0.04 meq/ml, respectively) and then it stabilized until day 88 on which it was 0.8 Ϯ 0.08 meq/ml, a level which was approximately 60% of the concentration found on day 18. These salivary sodium concentrations of the GVHD mice were lower than those of both control groups on days 25 to 88, a reduction which was statistically significant with respect to the NORM group on days 46 and 56 by 24% (P Ͻ 0.05) and 25% (P Ͻ 0.05), respectively; and by 34% (P Ͻ 0.05) with respect to the SYN group on day 46 ( Table  2 ). In contrast to the sodium, the salivary potassium concentration in the GVHD mice continuously increased during the experiment, an increase which was statistically significant on days 56 and 88 in comparison to day 18 (Table  3) . On day 88 the potassium concentration was 6.4 Ϯ 1.0 meq/ml and the increase was nearly double (P Ͻ 0.01) as compared to day 18 on which the concentration was of 3.3 Ϯ 0.1 meq/ml. When compared to the NORM and SYN control groups the mean salivary potassium concentrations in the GVHD mice were higher by 2.6-and 1.9-fold, respectively, on day 88 (Table 3) .
Histology
The histology analysis included quantitative evaluation of the levels of fibrosis, inflammatory infiltration and pyknosis. In the non-treated control group (NORM group) the analysis was done on days 18 and 88 and demonstrated no pathological alterations and thus the evaluation scoring was 0 for all three parameters and at both time points. In the SYN group there was a 0.2-0.6 of pyknosis levels throughout the experiment except for day 88 on which no pyknosis was found. The inflammatory infiltration and fibrosis levels of the SYN group on days 18 and 25 were 0. However, on days 46-88 the level of inflammatory infiltration was scored at 0.2-1.5 and that of fibrosis was scored at 0.2-0.5 (Table 4) . Undoubtedly, most of the pathological changes were observed in the GVHD group. While there was some similarity with respect to the pattern of changes regarding pyknosis between the GVHD and the SYN groups, the changes in inflammatory infiltration and fibrosis in the GVHD group were profound in contrast to those observed in both NORM and SYN control groups (Table  4 ). The level of pyknosis in the GVHD group was 0.7-2 on days 18-56 and dropped to 0.1 on day 88. The level of the inflammatory infiltration in the GVHD group increased from 0.6 on day 18 to 1.2-2.8 on days 25-88. The level of fibrosis in the GVHD group which was 0 on day 18 increased continuously throughout the experiment until it reached a level of 3.2 on day 88 (Table 4) .
Correlation between sialometric and histopathological parameters
As can be seen in Figure 4 an inverse correlation was observed between the mean parotid salivary flow rate and the degree of fibrosis observed in the histopathological evaluation of the GVHD mice (P Ͻ 0.01). Maximal flow rate 34.8 Ϯ 4.6 l/30 min was observed when no fibrosis was observed while in mice with maximal fibrosis flow rates were minimal ( Figure 4 ).
Discussion
The xerostomia reported in cGVHD patients is a known entity and a major complaint of these patients. 4, 9 The pathognomonic mechanism which causes this salivary hypofunction is not yet understood and neither is the correlation found between the disturbed salivary function and the histological alterations observed in the salivary glands. Using a mouse model, the current study enabled us to extensively and thoroughly evaluate the prolonged developing salivary alterations induced by the disease. [7] [8] [9] [10] We chose to evaluate parotid gland function as this major salivary gland secretes the largest volume of saliva into the oral cavity and as it was shown to be highly affected by the disease. 11, 12 We observed a prolonged significant reduction in the parotid salivary flow rate which correlated with the histopathological findings and fibrosis of the glands as well as alterations in the chemical composition of the saliva which lasted up to 3 months post cGVHD induction. The sialochemical alterations parallel the systemic manifestations of cGVHD, ie weight loss. At 5 weeks the mice in the experimental GVHD group weighed 88% of their original weight which is in agreement with previous publications with the B10.D2 to Balb/c model of cGVHD 13 and indicates that by using this model we may be able to induce clinically significant cGVHD.
The mean salivary flow rate of the non-treated control mice (NORM group) remained stable for about 3 months throughout the experiment with a mean value of 87.8 Ϯ 27.4 l/30 min which was similar to a previously reported value. 7 This flow rate was statistically higher than that found in the SYN control and GVHD experimental groups. In turn, the mean flow rate of the SYN group which also remained stable throughout the experiment at a level of 55.9 Ϯ 16.9 l/30 min was statistically higher than the mean flow rate of the GVHD group. On day 18 the mean flow rate of the GVHD group was 37.4 Ϯ 4.4 l/30 min which is closely similar to the 39.1 Ϯ 2.9 l/30 min previously reported 3 weeks after the induction of cGVHD in Table 4 The mean maximal changes of pyknosis, inflammation and fibrosis observed in the parotid glands of the GVHD, NORM and SYN groups at the various time points during the experiment Number of mice analyzed is given in parentheses while N depicts a specific data which was not obtained. the same mouse model. 7 However, in contrast to the two control groups the mean flow rate of the GVHD group decreased gradually and on days 56 and 88 the mean flow rates were 22.2 Ϯ 3.2 l/30 min and 14.8 Ϯ 3.8 l/30 min, respectively. Thus, on days 18 and 88 the mean flow rates of the GVHD group were lower than that of the SYN group by 43% (P Ͻ 0.04) and 65% (P Ͻ 0.01), respectively and lower than that of the NORM group by 63% (P Ͻ 0.02) and 85% (P Ͻ 0.01), respectively. As the only difference between the SYN and NORM groups was the preconditioning irradiation (850 cGy) to which the parotid glands were exposed we conclude that the flow rate reduction of 37% (P Ͻ 0.01) and 55% (P Ͻ 0.01) on days 46 and 88 in the SYN group are the result of irradiation-induced salivary injury as we published previously. [16] [17] [18] [19] In any case the reduction in flow rates of the GVHD group on days 46 and 88 were much higher than in the SYN group-64% (P Ͻ 0.01) and 83% (P Ͻ 0.01), respectively. Obviously this profound salivary hypofunction is induced by the cGVHD itself as no other differences between the GVHD and SYN group existed. The other functional parameter evaluated, the differential dynamic pattern of the salivary secretion similarly revealed that the GVHD group was the group of mice to be affected most drastically. At 5 min and at 30 min after stimulation the reductions in flow rates between the GVHD and NORM groups were 58% (P Ͻ 0.01) and 51%
Bone Marrow Transplantation (P Ͻ 0.03), and 77% (P Ͻ 0.01) and 87% (P Ͻ 0.01), respectively, on day 88. However, when we compared the mean flow rates on days 18 and 88 within the GVHD group itself there was a 48% reduction at 5 min and a 70% reduction at 30 min. In other words, the major salivary functional injury in cGVHD occurs at the later rather than the earlier phase of salivary secretion. The cGVHD-induced destructive effect may be targeting either the muscarinic receptor replacement or synthesis, the water transporter function or the synthesis or the Ca ϩϩ ions as these targets are functional at the later phase while the initial phase of salivary secretion is based on receptors and transporters already functioning prior to the stimulation which are saturated before the start of the later phase. The salivary electrolyte alterations demonstrated in the current study were essentially similar to those recently reported in cGVHD patients and in an identical model, ie a reduction in sodium with a concomitant increase in potassium. 7, 9 This may result from the reduction in the flow rate which enables the NaCl transporters of the secretion ducts to reabsorb more sodium from the saliva and secrete in return potassium into the saliva. 11, 12 However, this could also reflect the lower sodium and higher potassium concentrations found in the serum as lower concentrations of sodium were found in the serum of acute GVHD patients 20 and higher concentrations of potassium were found in the serum of mice in a GVHD model. 21 A significant correlation between the flow rate reduction and the increase in fibrosis was demonstrated in the GVHD group (Figure 4 ) with no correlation demonstrated between the flow rate reduction and the levels of either inflammatory infiltration or pyknosis. Thus at 30-40 days post cGVHD induction there was no significant reduction in flow rate yet a massive lymphocyte infiltration into the salivary parenchyma was demonstrated. However, at the later phase of 60-80 days, the level of fibrosis profoundly increased replacing this normal parenchyma with a concomitant extensive reduction of flow rate and a disappearance of previously demonstrated pyknosis. We and others previously highlighted the role of infiltrating lymphocyte and cytokine production resulting eventually in parenchymal replacement and fibrosis and in major salivary hypofunction observed in cGVHD both in a mouse model and humans. 7, [22] [23] [24] [25] [26] [27] In the current study, we observed an inverse correlation between parotid salivary flow rate and level of fibrosis but not with the degree of inflammatory infiltration.
In summary, the data presented seem to indicate that the severe xerostomia of the cGVHD patients is a life-long phenomenon as the salivary functional parenchyma is lost and replaced by fibrotic tissue. Consequently, a life-long therapy with oral pilocarpine or other therapeutic compounds may be indicated.
